Literature DB >> 11808089

Measurement of antiacetylcholine receptor antibody in patients with thymoma without myasthenia gravis complications.

M Sakuraba1, T Onuki, S Nitta.   

Abstract

OBJECTIVE: Some patients with thymoma reported to show higher antiacetylcholine receptor antibody titers without the preoperative occurrence of myasthenia gravis and some have suffered postoperative complications of myasthenia gravis despite being negative for antiacetylcholine receptor antibody preoperatively. We evaluated changes in antiacetylcholine receptor antibody titers and the occurrence of myasthenia gravis in thymoma patients.
METHODS: Subjects were 31 of 44 patients with thymoma undergoing thymothymectomy at Tokyo Women's Medical University Hospital between 1987 to 1999 in whom antiacetylcholine receptor antibody titers were measured preoperatively. We studied postoperative changes in antiacetylcholine receptor antibody titers and the presence or absence of myasthenia gravis.
RESULTS: Eight patients were positive for antiacetylcholine receptor antibody preoperatively, suggesting the presence of subclinical myasthenia gravis. Neither postoperative changes in antiacetylcholine receptor antibody titers nor the occurrence of myasthenia gravis was observed in these 8 patients. Recurrent thymoma and rapid elevation of antiacetylcholine receptor antibody titers were observed postoperatively in 1 patient negative for antiacetylcholine receptor antibody preoperatively, resulting in manifestation of myasthenia gravis symptoms.
CONCLUSION: We found no correlation between preoperative titers and myasthenia gravis symptoms. Rapid titer elevation indicates the occurrence of myasthenia gravis symptoms or the recurrence of thymoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11808089     DOI: 10.1007/bf02913506

Source DB:  PubMed          Journal:  Jpn J Thorac Cardiovasc Surg        ISSN: 1344-4964


  7 in total

1.  [A retrospective group study on post-thymectomy myasthenia gravis].

Authors:  M Ito; S Fujimura; Y Monden; Y Watanabe; N Shimizu; T Hirono; K Iuchi; N Tsubota; A Masaoka
Journal:  Nihon Kyobu Geka Gakkai Zasshi       Date:  1992-02

2.  Acetylcholine receptor antibody measurements in acquired myasthenia gravis. Diagnostic sensitivity and predictive value for thymoma.

Authors:  A M Husain; J M Massey; J F Howard; D B Sanders
Journal:  Ann N Y Acad Sci       Date:  1998-05-13       Impact factor: 5.691

3.  Anti-titin and antiryanodine receptor antibodies in myasthenia gravis patients with thymoma.

Authors:  F Baggi; F Andreetta; C Antozzi; O Simoncini; P Confalonieri; S Labeit; F Cornelio; R Mantegazza
Journal:  Ann N Y Acad Sci       Date:  1998-05-13       Impact factor: 5.691

Review 4.  Muscle striation antibodies in myasthenia gravis. Diagnostic and functional significance.

Authors:  J A Aarli; G O Skeie; A Mygland; N E Gilhus
Journal:  Ann N Y Acad Sci       Date:  1998-05-13       Impact factor: 5.691

5.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

6.  Anti-skeletal muscle and anti-acetylcholine receptor antibodies in patients with thymoma without myasthenia gravis: relation to the onset of myasthenia gravis.

Authors:  M Ohta; M Itoh; H Hara; N Itoh; H Nishitani; K Hayashi; K Ohta
Journal:  Clin Chim Acta       Date:  1991-09-30       Impact factor: 3.786

7.  Acetylcholine receptor antibody production by bone marrow cells in a patient with myasthenia gravis.

Authors:  Y Fujii; Y Monden; J Hashimoto; K Nakahara; Y Kawashima
Journal:  Neurology       Date:  1985-04       Impact factor: 9.910

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.